| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Zika Virus | 24 | 2019 | 1924 | 3.99 | Why? |
| Zika Virus Infection | 23 | 2019 | 1920 | 3.83 | Why? |
| West Nile virus | 14 | 2018 | 206 | 2.24 | Why? |
| Chikungunya virus | 7 | 2019 | 339 | 2.00 | Why? |
| Antibodies, Monoclonal | 22 | 2021 | 8041 | 1.76 | Why? |
| Mice | 57 | 2021 | 21357 | 1.70 | Why? |
| Viral Vaccines | 13 | 2021 | 7560 | 1.68 | Why? |
| Mice, Inbred C57BL | 33 | 2021 | 5542 | 1.57 | Why? |
| Membrane Proteins | 6 | 2021 | 1733 | 1.26 | Why? |
| Disease Models, Animal | 25 | 2021 | 10998 | 1.25 | Why? |
| West Nile Fever | 8 | 2017 | 166 | 1.22 | Why? |
| Antibodies, Neutralizing | 34 | 2021 | 25288 | 1.20 | Why? |
| Dengue Virus | 8 | 2018 | 910 | 1.11 | Why? |
| Animals | 86 | 2021 | 78931 | 1.11 | Why? |
| Immunoglobulins | 2 | 2019 | 811 | 1.01 | Why? |
| Antibodies, Viral | 38 | 2021 | 51949 | 0.98 | Why? |
| Immunoglobulin Fc Fragments | 3 | 2021 | 691 | 0.94 | Why? |
| Carrier Proteins | 5 | 2018 | 513 | 0.91 | Why? |
| Chikungunya Fever | 3 | 2019 | 345 | 0.85 | Why? |
| Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2019 | 41 | 0.83 | Why? |
| Vero Cells | 25 | 2021 | 14117 | 0.81 | Why? |
| Gorilla gorilla | 1 | 2019 | 53 | 0.79 | Why? |
| Drosophila Proteins | 1 | 2019 | 67 | 0.78 | Why? |
| Flavivirus | 2 | 2018 | 182 | 0.77 | Why? |
| Drosophila melanogaster | 1 | 2019 | 85 | 0.77 | Why? |
| RNA Caps | 2 | 2012 | 204 | 0.76 | Why? |
| Lymphoid Tissue | 1 | 2019 | 162 | 0.76 | Why? |
| O'nyong-nyong Virus | 1 | 2018 | 9 | 0.75 | Why? |
| Hydro-Lyases | 1 | 2018 | 14 | 0.75 | Why? |
| Alphavirus | 1 | 2019 | 90 | 0.75 | Why? |
| Vesicular stomatitis Indiana virus | 2 | 2020 | 354 | 0.74 | Why? |
| Fetal Diseases | 2 | 2018 | 182 | 0.74 | Why? |
| Encephalitis Virus, Venezuelan Equine | 2 | 2018 | 71 | 0.69 | Why? |
| Mice, Knockout | 11 | 2020 | 1815 | 0.67 | Why? |
| Myeloid Cells | 3 | 2021 | 808 | 0.67 | Why? |
| Neutralization Tests | 11 | 2021 | 6698 | 0.67 | Why? |
| Virus Cultivation | 1 | 2020 | 579 | 0.64 | Why? |
| Adenoviridae | 2 | 2020 | 1151 | 0.64 | Why? |
| B-Lymphocytes | 11 | 2021 | 4418 | 0.63 | Why? |
| Receptor, Interferon alpha-beta | 7 | 2018 | 610 | 0.62 | Why? |
| Alphavirus Infections | 1 | 2016 | 68 | 0.61 | Why? |
| Interferon Type I | 7 | 2021 | 2789 | 0.60 | Why? |
| Mice, Transgenic | 7 | 2021 | 2739 | 0.59 | Why? |
| Interferons | 4 | 2020 | 2885 | 0.58 | Why? |
| Virus Physiological Phenomena | 1 | 2017 | 155 | 0.57 | Why? |
| Dengue | 7 | 2018 | 1565 | 0.56 | Why? |
| Immunity, Innate | 8 | 2021 | 6570 | 0.55 | Why? |
| Vaccines, DNA | 2 | 2021 | 871 | 0.55 | Why? |
| Spike Glycoprotein, Coronavirus | 24 | 2021 | 37182 | 0.54 | Why? |
| CD8-Positive T-Lymphocytes | 7 | 2021 | 5837 | 0.48 | Why? |
| Viral Tropism | 2 | 2019 | 1329 | 0.48 | Why? |
| Administration, Intranasal | 3 | 2021 | 1132 | 0.47 | Why? |
| Vaccines, Subunit | 4 | 2021 | 1088 | 0.47 | Why? |
| Peptidyl-Dipeptidase A | 10 | 2020 | 9659 | 0.47 | Why? |
| Methyltransferases | 3 | 2012 | 720 | 0.45 | Why? |
| Mice, Inbred BALB C | 8 | 2021 | 5814 | 0.45 | Why? |
| Immunity | 3 | 2019 | 2651 | 0.45 | Why? |
| Virus Inactivation | 2 | 2020 | 1139 | 0.44 | Why? |
| Receptors, Virus | 5 | 2021 | 5659 | 0.44 | Why? |
| Virus Replication | 15 | 2021 | 14331 | 0.43 | Why? |
| Protein Binding | 11 | 2021 | 11430 | 0.43 | Why? |
| Infectious Disease Transmission, Vertical | 5 | 2018 | 5164 | 0.42 | Why? |
| Adaptor Proteins, Signal Transducing | 6 | 2018 | 502 | 0.39 | Why? |
| Mutation | 8 | 2021 | 12376 | 0.38 | Why? |
| Mycobacterium tuberculosis | 1 | 2018 | 1164 | 0.37 | Why? |
| Germinal Center | 2 | 2021 | 332 | 0.36 | Why? |
| Immunogenicity, Vaccine | 2 | 2021 | 4624 | 0.36 | Why? |
| Blood-Brain Barrier | 3 | 2017 | 531 | 0.33 | Why? |
| Fibroblasts | 3 | 2018 | 839 | 0.33 | Why? |
| Viruses | 2 | 2017 | 2238 | 0.32 | Why? |
| HEK293 Cells | 10 | 2021 | 8394 | 0.32 | Why? |
| Fetus | 3 | 2019 | 484 | 0.32 | Why? |
| T-Lymphocytes | 7 | 2021 | 6670 | 0.31 | Why? |
| Intracellular Signaling Peptides and Proteins | 2 | 2018 | 334 | 0.31 | Why? |
| Lipids | 3 | 2017 | 1079 | 0.30 | Why? |
| eIF-2 Kinase | 1 | 2006 | 117 | 0.30 | Why? |
| RNA, Messenger | 2 | 2017 | 5131 | 0.30 | Why? |
| Epitopes | 6 | 2021 | 4113 | 0.30 | Why? |
| Indolizines | 1 | 2005 | 41 | 0.30 | Why? |
| Virus Diseases | 3 | 2019 | 3779 | 0.30 | Why? |
| Vaccines, Attenuated | 3 | 2021 | 952 | 0.29 | Why? |
| 3T3 Cells | 2 | 2018 | 152 | 0.29 | Why? |
| Pregnancy Complications, Infectious | 4 | 2018 | 11559 | 0.29 | Why? |
| Microcephaly | 2 | 2017 | 181 | 0.29 | Why? |
| Cross Reactions | 7 | 2021 | 4374 | 0.28 | Why? |
| Betacoronavirus | 15 | 2020 | 204454 | 0.28 | Why? |
| Primates | 2 | 2018 | 584 | 0.28 | Why? |
| Methylation | 4 | 2018 | 332 | 0.27 | Why? |
| Containment of Biohazards | 2 | 2021 | 762 | 0.27 | Why? |
| Vaccines, Virus-Like Particle | 2 | 2021 | 312 | 0.27 | Why? |
| CHO Cells | 3 | 2021 | 831 | 0.27 | Why? |
| Pregnancy | 11 | 2019 | 23879 | 0.27 | Why? |
| Virus Internalization | 10 | 2021 | 7921 | 0.27 | Why? |
| Cell Line | 14 | 2021 | 12040 | 0.27 | Why? |
| Aedes | 2 | 2018 | 380 | 0.27 | Why? |
| Proteins | 2 | 2017 | 921 | 0.27 | Why? |
| Cricetulus | 3 | 2021 | 936 | 0.27 | Why? |
| Cricetinae | 6 | 2021 | 3344 | 0.26 | Why? |
| RNA-Binding Proteins | 4 | 2018 | 1022 | 0.26 | Why? |
| Meningoencephalitis | 1 | 2006 | 208 | 0.26 | Why? |
| Spleen | 4 | 2019 | 877 | 0.26 | Why? |
| Immunologic Factors | 2 | 2017 | 4206 | 0.26 | Why? |
| Genetic Vectors | 2 | 2021 | 1600 | 0.26 | Why? |
| Signal Transduction | 7 | 2021 | 7207 | 0.25 | Why? |
| Serine Endopeptidases | 6 | 2021 | 4606 | 0.25 | Why? |
| Vaccines, Synthetic | 3 | 2021 | 3231 | 0.24 | Why? |
| Adaptive Immunity | 3 | 2019 | 2585 | 0.24 | Why? |
| Humans | 71 | 2021 | 930598 | 0.24 | Why? |
| RNA, Small Interfering | 2 | 2017 | 817 | 0.24 | Why? |
| Female | 37 | 2021 | 380317 | 0.24 | Why? |
| Serine C-Palmitoyltransferase | 1 | 2021 | 20 | 0.24 | Why? |
| Transcription, Genetic | 2 | 2019 | 1326 | 0.24 | Why? |
| Cytokines | 5 | 2021 | 15010 | 0.24 | Why? |
| Green Fluorescent Proteins | 2 | 2020 | 450 | 0.24 | Why? |
| Endoribonucleases | 1 | 2006 | 407 | 0.23 | Why? |
| Immunodominant Epitopes | 3 | 2021 | 813 | 0.23 | Why? |
| Tuberculosis | 1 | 2018 | 2895 | 0.23 | Why? |
| Interferon-gamma | 3 | 2020 | 2711 | 0.23 | Why? |
| Genetic Complementation Test | 2 | 2021 | 59 | 0.22 | Why? |
| Neoplasm Proteins | 2 | 2021 | 501 | 0.22 | Why? |
| Endothelial Cells | 1 | 2012 | 2048 | 0.22 | Why? |
| CRISPR-Cas Systems | 3 | 2019 | 1397 | 0.22 | Why? |
| Interferon-Induced Helicase, IFIH1 | 3 | 2021 | 245 | 0.22 | Why? |
| Mice, Inbred DBA | 1 | 2020 | 56 | 0.22 | Why? |
| Gene Expression Regulation | 3 | 2021 | 4020 | 0.21 | Why? |
| Viral Load | 6 | 2021 | 15850 | 0.21 | Why? |
| Hydroxycholesterols | 1 | 2020 | 85 | 0.21 | Why? |
| Receptors, Fc | 2 | 2018 | 153 | 0.21 | Why? |
| Keratin-18 | 1 | 2020 | 114 | 0.21 | Why? |
| Antibodies, Blocking | 2 | 2018 | 174 | 0.21 | Why? |
| Pneumonia | 1 | 2020 | 5652 | 0.21 | Why? |
| Neurons | 1 | 2006 | 864 | 0.20 | Why? |
| Neutrophil Infiltration | 1 | 2020 | 201 | 0.20 | Why? |
| Cross-Priming | 1 | 2018 | 9 | 0.20 | Why? |
| Culicidae | 2 | 2018 | 239 | 0.20 | Why? |
| Organ Specificity | 2 | 2019 | 1070 | 0.20 | Why? |
| Models, Molecular | 12 | 2021 | 7616 | 0.20 | Why? |
| Transduction, Genetic | 1 | 2020 | 273 | 0.19 | Why? |
| Heterocyclic Compounds, 4 or More Rings | 1 | 2020 | 139 | 0.19 | Why? |
| Coronavirus Infections | 15 | 2020 | 253789 | 0.19 | Why? |
| Pneumonia, Viral | 14 | 2020 | 243684 | 0.19 | Why? |
| Placenta | 3 | 2018 | 1531 | 0.19 | Why? |
| Chondrocytes | 1 | 2018 | 35 | 0.19 | Why? |
| Exonucleases | 1 | 2018 | 52 | 0.19 | Why? |
| Immunization, Passive | 5 | 2021 | 10067 | 0.18 | Why? |
| Viral Envelope Proteins | 5 | 2020 | 3539 | 0.18 | Why? |
| Encephalitis, Viral | 1 | 2003 | 355 | 0.18 | Why? |
| Viral Plaque Assay | 1 | 2020 | 381 | 0.18 | Why? |
| Morpholines | 1 | 2020 | 351 | 0.18 | Why? |
| Chick Embryo | 1 | 2018 | 249 | 0.18 | Why? |
| Ampicillin | 1 | 2018 | 73 | 0.18 | Why? |
| Cecum | 1 | 2018 | 63 | 0.18 | Why? |
| Antigens, Viral | 4 | 2020 | 6298 | 0.18 | Why? |
| Interferon Regulatory Factor-1 | 1 | 2017 | 33 | 0.18 | Why? |
| Phosphatidylinositol 3-Kinases | 1 | 2020 | 347 | 0.18 | Why? |
| Antibody Formation | 3 | 2021 | 4038 | 0.18 | Why? |
| Triazines | 1 | 2020 | 246 | 0.18 | Why? |
| Protective Agents | 1 | 2021 | 250 | 0.18 | Why? |
| Lectins, C-Type | 1 | 2021 | 405 | 0.18 | Why? |
| Plasma Cells | 1 | 2021 | 464 | 0.18 | Why? |
| Culture Media | 1 | 2020 | 366 | 0.18 | Why? |
| West Nile Virus Vaccines | 1 | 2017 | 4 | 0.18 | Why? |
| Succinates | 1 | 2018 | 79 | 0.18 | Why? |
| RNA Helicases | 2 | 2018 | 413 | 0.17 | Why? |
| Immunologic Techniques | 1 | 2017 | 71 | 0.17 | Why? |
| Osteoblasts | 1 | 2018 | 87 | 0.17 | Why? |
| Homeodomain Proteins | 1 | 2018 | 93 | 0.17 | Why? |
| Receptors, Interferon | 1 | 2017 | 64 | 0.17 | Why? |
| Oncolytic Virotherapy | 1 | 2017 | 36 | 0.17 | Why? |
| Antibody-Dependent Enhancement | 2 | 2018 | 413 | 0.17 | Why? |
| Mice, 129 Strain | 1 | 2017 | 36 | 0.17 | Why? |
| Enterocytes | 1 | 2020 | 245 | 0.17 | Why? |
| Injections, Intramuscular | 1 | 2020 | 800 | 0.17 | Why? |
| Immunoglobulin Fab Fragments | 4 | 2021 | 556 | 0.17 | Why? |
| Cryoelectron Microscopy | 7 | 2020 | 2372 | 0.17 | Why? |
| Male | 24 | 2021 | 367725 | 0.17 | Why? |
| Maternal-Fetal Exchange | 1 | 2019 | 209 | 0.17 | Why? |
| Malaria, Cerebral | 1 | 2017 | 37 | 0.17 | Why? |
| STAT2 Transcription Factor | 1 | 2018 | 141 | 0.17 | Why? |
| Nervous System Malformations | 1 | 2017 | 43 | 0.17 | Why? |
| Embryo, Mammalian | 1 | 2017 | 86 | 0.17 | Why? |
| Endosomes | 1 | 2020 | 490 | 0.17 | Why? |
| Nanoparticles | 2 | 2021 | 2040 | 0.17 | Why? |
| RNA, Viral | 8 | 2021 | 32276 | 0.17 | Why? |
| Antigens, Protozoan | 1 | 2017 | 121 | 0.16 | Why? |
| Antigens, Neoplasm | 1 | 2018 | 230 | 0.16 | Why? |
| Pandemics | 17 | 2021 | 389249 | 0.16 | Why? |
| Multiprotein Complexes | 1 | 2017 | 182 | 0.16 | Why? |
| Blood Cells | 1 | 2017 | 104 | 0.16 | Why? |
| Post-Exposure Prophylaxis | 1 | 2021 | 472 | 0.16 | Why? |
| Specific Pathogen-Free Organisms | 1 | 2017 | 358 | 0.16 | Why? |
| Promoter Regions, Genetic | 1 | 2020 | 823 | 0.16 | Why? |
| Neoplastic Stem Cells | 1 | 2017 | 120 | 0.16 | Why? |
| Macaca mulatta | 3 | 2021 | 3716 | 0.16 | Why? |
| Protozoan Proteins | 1 | 2017 | 205 | 0.15 | Why? |
| Protein Domains | 5 | 2021 | 6563 | 0.15 | Why? |
| Macrophages | 3 | 2016 | 2784 | 0.15 | Why? |
| Epitopes, B-Lymphocyte | 3 | 2020 | 1267 | 0.15 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.15 | Why? |
| Mesocricetus | 1 | 2021 | 1847 | 0.15 | Why? |
| Receptor Protein-Tyrosine Kinases | 1 | 2017 | 243 | 0.15 | Why? |
| Arthritis | 1 | 2019 | 288 | 0.15 | Why? |
| Vagina | 1 | 2018 | 327 | 0.15 | Why? |
| Viral Nonstructural Proteins | 4 | 2018 | 4810 | 0.14 | Why? |
| Human Umbilical Vein Endothelial Cells | 1 | 2017 | 286 | 0.14 | Why? |
| Cells, Cultured | 6 | 2021 | 5835 | 0.14 | Why? |
| Pre-Exposure Prophylaxis | 2 | 2021 | 1138 | 0.14 | Why? |
| Clinical Trials as Topic | 3 | 2021 | 7330 | 0.14 | Why? |
| Brain Edema | 1 | 2017 | 224 | 0.14 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 372 | 0.14 | Why? |
| Viral Proteins | 5 | 2018 | 7370 | 0.14 | Why? |
| TOR Serine-Threonine Kinases | 1 | 2017 | 385 | 0.14 | Why? |
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 245 | 0.14 | Why? |
| DEAD Box Protein 58 | 1 | 2017 | 250 | 0.14 | Why? |
| Glioblastoma | 1 | 2017 | 187 | 0.14 | Why? |
| Complement System Proteins | 1 | 2018 | 380 | 0.14 | Why? |
| Fetal Death | 1 | 2018 | 390 | 0.14 | Why? |
| Gene Deletion | 1 | 2016 | 430 | 0.14 | Why? |
| Proto-Oncogene Proteins | 1 | 2017 | 340 | 0.14 | Why? |
| Astrocytes | 1 | 2017 | 298 | 0.14 | Why? |
| Host-Pathogen Interactions | 5 | 2021 | 11041 | 0.14 | Why? |
| Exoribonucleases | 1 | 2018 | 455 | 0.13 | Why? |
| Guillain-Barre Syndrome | 2 | 2017 | 1495 | 0.13 | Why? |
| Immunologic Memory | 3 | 2021 | 3362 | 0.13 | Why? |
| Furin | 1 | 2021 | 1054 | 0.13 | Why? |
| Ebolavirus | 1 | 2020 | 834 | 0.13 | Why? |
| Leukocytes | 1 | 2020 | 1046 | 0.13 | Why? |
| Syndrome | 1 | 2018 | 1310 | 0.13 | Why? |
| Protein Conformation | 4 | 2021 | 4386 | 0.13 | Why? |
| Viral Structural Proteins | 1 | 2017 | 491 | 0.13 | Why? |
| Golgi Apparatus | 3 | 2008 | 178 | 0.12 | Why? |
| NF-kappa B | 1 | 2020 | 1301 | 0.12 | Why? |
| Killer Cells, Natural | 2 | 2020 | 2093 | 0.12 | Why? |
| Flow Cytometry | 2 | 2020 | 2393 | 0.12 | Why? |
| Lung | 5 | 2021 | 31049 | 0.12 | Why? |
| Malaria, Falciparum | 1 | 2017 | 377 | 0.12 | Why? |
| Neutrophils | 2 | 2020 | 5476 | 0.12 | Why? |
| Cell Survival | 1 | 2018 | 1581 | 0.12 | Why? |
| Rats | 1 | 2020 | 2764 | 0.12 | Why? |
| Antiviral Agents | 7 | 2021 | 41703 | 0.12 | Why? |
| HIV Antibodies | 1 | 2018 | 776 | 0.12 | Why? |
| Transfection | 3 | 2020 | 864 | 0.12 | Why? |
| SARS Virus | 7 | 2021 | 13021 | 0.12 | Why? |
| Interferon-beta | 1 | 2018 | 979 | 0.11 | Why? |
| Gestational Age | 1 | 2017 | 1488 | 0.11 | Why? |
| Ethics, Medical | 1 | 2018 | 533 | 0.11 | Why? |
| Reactive Oxygen Species | 1 | 2018 | 1136 | 0.11 | Why? |
| Epitope Mapping | 3 | 2021 | 1240 | 0.11 | Why? |
| Poxviridae | 1 | 2010 | 23 | 0.11 | Why? |
| Respiratory Mucosa | 1 | 2020 | 1522 | 0.11 | Why? |
| Inflammation | 3 | 2019 | 13255 | 0.11 | Why? |
| Muscle, Skeletal | 1 | 2018 | 915 | 0.11 | Why? |
| Drug Evaluation, Preclinical | 3 | 2017 | 3347 | 0.11 | Why? |
| Clone Cells | 2 | 2021 | 312 | 0.11 | Why? |
| Drug Resistance, Viral | 1 | 2017 | 1083 | 0.11 | Why? |
| Metabolomics | 1 | 2017 | 921 | 0.11 | Why? |
| Binding Sites | 6 | 2021 | 6201 | 0.10 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.10 | Why? |
| Binding, Competitive | 2 | 2021 | 264 | 0.10 | Why? |
| DEAD-box RNA Helicases | 1 | 2011 | 99 | 0.10 | Why? |
| Lymphocyte Activation | 1 | 2020 | 2742 | 0.10 | Why? |
| Brain Neoplasms | 1 | 2017 | 669 | 0.10 | Why? |
| Autophagy | 1 | 2017 | 960 | 0.10 | Why? |
| Proteomics | 2 | 2021 | 2481 | 0.10 | Why? |
| Apoptosis Regulatory Proteins | 1 | 2010 | 202 | 0.10 | Why? |
| Vaccines, Inactivated | 1 | 2017 | 1562 | 0.10 | Why? |
| Swine | 1 | 2018 | 3352 | 0.10 | Why? |
| Epithelial Cells | 2 | 2019 | 3508 | 0.10 | Why? |
| Transcriptome | 2 | 2021 | 3466 | 0.10 | Why? |
| Orthomyxoviridae | 1 | 2017 | 1168 | 0.09 | Why? |
| Mice, Mutant Strains | 2 | 2018 | 42 | 0.09 | Why? |
| Vaccination | 5 | 2021 | 19050 | 0.09 | Why? |
| RNA Interference | 2 | 2017 | 534 | 0.09 | Why? |
| Models, Genetic | 1 | 2010 | 434 | 0.09 | Why? |
| Drug Design | 1 | 2020 | 2627 | 0.09 | Why? |
| Lung Diseases | 2 | 2021 | 2361 | 0.09 | Why? |
| Monocytes | 1 | 2020 | 2978 | 0.09 | Why? |
| Microbiota | 1 | 2018 | 1240 | 0.09 | Why? |
| Superior Cervical Ganglion | 1 | 2006 | 3 | 0.08 | Why? |
| Cerebellar Cortex | 1 | 2006 | 5 | 0.08 | Why? |
| Gene Expression | 1 | 2018 | 3332 | 0.08 | Why? |
| Monitoring, Physiologic | 1 | 2018 | 1956 | 0.08 | Why? |
| Cytoplasm | 2 | 2005 | 304 | 0.08 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2017 | 1261 | 0.08 | Why? |
| Protein Engineering | 2 | 2021 | 536 | 0.08 | Why? |
| Central Nervous System | 1 | 2012 | 701 | 0.08 | Why? |
| Protein Biosynthesis | 1 | 2010 | 653 | 0.08 | Why? |
| Electroporation | 1 | 2005 | 52 | 0.08 | Why? |
| Time Factors | 4 | 2021 | 31397 | 0.08 | Why? |
| Tight Junctions | 2 | 2017 | 179 | 0.08 | Why? |
| Bacteria | 1 | 2017 | 1897 | 0.08 | Why? |
| Patient Safety | 1 | 2021 | 4885 | 0.07 | Why? |
| Virulence | 3 | 2021 | 2172 | 0.07 | Why? |
| Autoimmune Diseases | 1 | 2019 | 1996 | 0.07 | Why? |
| Disease Susceptibility | 1 | 2018 | 4002 | 0.07 | Why? |
| Models, Immunological | 1 | 2010 | 727 | 0.07 | Why? |
| Brain | 2 | 2018 | 5133 | 0.07 | Why? |
| Immunoassay | 1 | 2020 | 4485 | 0.07 | Why? |
| Protein Stability | 2 | 2018 | 756 | 0.07 | Why? |
| Protein Structure, Tertiary | 3 | 2021 | 1565 | 0.07 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.07 | Why? |
| Mice, Congenic | 1 | 2003 | 2 | 0.07 | Why? |
| Species Specificity | 2 | 2018 | 1356 | 0.07 | Why? |
| Amino Acid Substitution | 2 | 2021 | 1706 | 0.07 | Why? |
| Yellow fever virus | 1 | 2005 | 205 | 0.06 | Why? |
| Viremia | 2 | 2018 | 1020 | 0.06 | Why? |
| Drug Discovery | 1 | 2017 | 3092 | 0.06 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2020 | 11367 | 0.06 | Why? |
| Cell Membrane | 1 | 2008 | 743 | 0.06 | Why? |
| Mutagenesis | 2 | 2021 | 394 | 0.06 | Why? |
| Structure-Activity Relationship | 2 | 2021 | 2219 | 0.06 | Why? |
| Amino Acid Motifs | 2 | 2020 | 620 | 0.06 | Why? |
| Immunoglobulin G | 6 | 2021 | 21571 | 0.06 | Why? |
| Virion | 2 | 2013 | 1444 | 0.06 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2017 | 4545 | 0.06 | Why? |
| Protein Interaction Domains and Motifs | 2 | 2020 | 2134 | 0.06 | Why? |
| Amino Acid Sequence | 3 | 2021 | 6049 | 0.06 | Why? |
| Vaccines | 1 | 2020 | 3692 | 0.06 | Why? |
| Down-Regulation | 2 | 2017 | 1416 | 0.05 | Why? |
| Open Reading Frames | 2 | 2006 | 1898 | 0.05 | Why? |
| Cell Line, Tumor | 2 | 2021 | 3608 | 0.05 | Why? |
| Immune Evasion | 2 | 2021 | 2081 | 0.05 | Why? |
| Cell Cycle | 1 | 2021 | 329 | 0.05 | Why? |
| Up-Regulation | 2 | 2018 | 2249 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.05 | Why? |
| RNA | 2 | 2018 | 1278 | 0.05 | Why? |
| Vesiculovirus | 1 | 2020 | 153 | 0.05 | Why? |
| Mutant Proteins | 1 | 2021 | 328 | 0.05 | Why? |
| Binding Sites, Antibody | 1 | 2021 | 466 | 0.05 | Why? |
| Severe Acute Respiratory Syndrome | 2 | 2020 | 12361 | 0.05 | Why? |
| Gene Expression Profiling | 2 | 2021 | 3788 | 0.05 | Why? |
| Heparitin Sulfate | 1 | 2021 | 285 | 0.05 | Why? |
| Duodenum | 1 | 2020 | 179 | 0.05 | Why? |
| Antigen-Antibody Reactions | 1 | 2021 | 616 | 0.05 | Why? |
| Basic-Leucine Zipper Transcription Factors | 1 | 2018 | 19 | 0.05 | Why? |
| Hydrazones | 1 | 2020 | 216 | 0.05 | Why? |
| Phagocytosis | 1 | 2021 | 409 | 0.05 | Why? |
| Toxoplasma | 1 | 2018 | 61 | 0.05 | Why? |
| Decidua | 1 | 2018 | 32 | 0.05 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.05 | Why? |
| ROC Curve | 2 | 2021 | 6024 | 0.05 | Why? |
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2017 | 15 | 0.05 | Why? |
| Toxoplasmosis | 1 | 2018 | 59 | 0.04 | Why? |
| Immune Sera | 1 | 2003 | 884 | 0.04 | Why? |
| B-Cell Activation Factor Receptor | 1 | 2017 | 33 | 0.04 | Why? |
| Protein Subunits | 1 | 2021 | 755 | 0.04 | Why? |
| Antibody-Dependent Cell Cytotoxicity | 1 | 2020 | 349 | 0.04 | Why? |
| Dacarbazine | 1 | 2017 | 67 | 0.04 | Why? |
| Cell Surface Display Techniques | 1 | 2018 | 170 | 0.04 | Why? |
| Microscopy, Electron | 1 | 2020 | 830 | 0.04 | Why? |
| Microscopy, Fluorescence | 1 | 2018 | 335 | 0.04 | Why? |
| Neoplasms, Experimental | 1 | 2017 | 67 | 0.04 | Why? |
| Antineoplastic Agents, Alkylating | 1 | 2017 | 71 | 0.04 | Why? |
| Feedback, Physiological | 1 | 2017 | 56 | 0.04 | Why? |
| Flavivirus Infections | 1 | 2018 | 81 | 0.04 | Why? |
| Viral Matrix Proteins | 1 | 2006 | 1243 | 0.04 | Why? |
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2017 | 78 | 0.04 | Why? |
| DNA Replication | 1 | 2017 | 121 | 0.04 | Why? |
| Encephalitis Viruses, Tick-Borne | 1 | 2018 | 100 | 0.04 | Why? |
| Molecular Conformation | 1 | 2018 | 374 | 0.04 | Why? |
| Repressor Proteins | 1 | 2018 | 232 | 0.04 | Why? |
| Interferon Regulatory Factors | 1 | 2017 | 141 | 0.04 | Why? |
| Dengue Vaccines | 1 | 2018 | 123 | 0.04 | Why? |
| Rotavirus | 1 | 2020 | 329 | 0.04 | Why? |
| Dissent and Disputes | 1 | 2018 | 117 | 0.04 | Why? |
| Gene Editing | 1 | 2020 | 330 | 0.04 | Why? |
| Crystallography, X-Ray | 3 | 2013 | 2689 | 0.04 | Why? |
| Proteolysis | 1 | 2021 | 751 | 0.04 | Why? |
| Insecta | 1 | 2017 | 122 | 0.04 | Why? |
| Membrane Fusion | 1 | 2020 | 713 | 0.04 | Why? |
| Pericytes | 1 | 2017 | 108 | 0.04 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.04 | Why? |
| Mass Spectrometry | 2 | 2017 | 1165 | 0.04 | Why? |
| Lymph Nodes | 1 | 2003 | 1060 | 0.04 | Why? |
| Survival Rate | 1 | 2010 | 9206 | 0.04 | Why? |
| Adoptive Transfer | 1 | 2017 | 250 | 0.04 | Why? |
| Immunophenotyping | 1 | 2020 | 1290 | 0.04 | Why? |
| Healthy Volunteers | 1 | 2021 | 1444 | 0.04 | Why? |
| Trophoblasts | 1 | 2017 | 237 | 0.04 | Why? |
| Genetic Testing | 1 | 2018 | 395 | 0.04 | Why? |
| A549 Cells | 1 | 2021 | 2066 | 0.03 | Why? |
| Reagent Kits, Diagnostic | 1 | 2005 | 2149 | 0.03 | Why? |
| Chemokines | 1 | 2021 | 1095 | 0.03 | Why? |
| Fluorescent Antibody Technique | 1 | 2017 | 835 | 0.03 | Why? |
| Glycosylation | 1 | 2018 | 1255 | 0.03 | Why? |
| Single-Domain Antibodies | 1 | 2021 | 744 | 0.03 | Why? |
| Phosphorylation | 1 | 2017 | 1060 | 0.03 | Why? |
| Microscopy, Confocal | 2 | 2006 | 343 | 0.03 | Why? |
| Cell Movement | 1 | 2017 | 695 | 0.03 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 7868 | 0.03 | Why? |
| Organoids | 1 | 2020 | 840 | 0.03 | Why? |
| Immunity, Humoral | 2 | 2018 | 4849 | 0.03 | Why? |
| Ferritins | 1 | 2021 | 2055 | 0.03 | Why? |
| Pyrimidines | 1 | 2020 | 1557 | 0.03 | Why? |
| Endoplasmic Reticulum | 2 | 2006 | 430 | 0.03 | Why? |
| Testis | 1 | 2017 | 566 | 0.03 | Why? |
| Transcription Factors | 1 | 2017 | 784 | 0.03 | Why? |
| Adjuvants, Immunologic | 1 | 2021 | 1709 | 0.03 | Why? |
| Ribose | 1 | 2011 | 42 | 0.03 | Why? |
| Coronavirus | 2 | 2011 | 18339 | 0.03 | Why? |
| Wearable Electronic Devices | 1 | 2018 | 694 | 0.03 | Why? |
| Antibodies | 1 | 2017 | 846 | 0.03 | Why? |
| Protein Multimerization | 1 | 2017 | 1336 | 0.03 | Why? |
| Single-Cell Analysis | 1 | 2021 | 2450 | 0.03 | Why? |
| Neoplasms | 1 | 2019 | 17251 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2018 | 27595 | 0.03 | Why? |
| Receptors, Pattern Recognition | 1 | 2011 | 128 | 0.03 | Why? |
| Phosphoproteins | 1 | 2020 | 4346 | 0.03 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2021 | 2654 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3633 | 0.02 | Why? |
| Models, Biological | 2 | 2021 | 4907 | 0.02 | Why? |
| Immunization Programs | 1 | 2021 | 2006 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2018 | 2483 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2017 | 3395 | 0.02 | Why? |
| Dendritic Cells | 1 | 2017 | 1330 | 0.02 | Why? |
| Evolution, Molecular | 1 | 2021 | 3691 | 0.02 | Why? |
| Fluorescent Antibody Technique, Indirect | 1 | 2008 | 393 | 0.02 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.02 | Why? |
| CD4 Antigens | 1 | 2008 | 306 | 0.02 | Why? |
| Adult | 3 | 2021 | 244371 | 0.02 | Why? |
| Precipitin Tests | 1 | 2005 | 40 | 0.02 | Why? |
| Computational Biology | 1 | 2021 | 4514 | 0.02 | Why? |
| Sequence Homology, Amino Acid | 1 | 2008 | 945 | 0.02 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2017 | 2262 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2003 | 9091 | 0.02 | Why? |
| Electronic Health Records | 1 | 2018 | 3492 | 0.02 | Why? |
| Biological Transport | 1 | 2006 | 290 | 0.02 | Why? |
| Molecular Docking Simulation | 1 | 2020 | 6902 | 0.02 | Why? |
| Sequence Analysis, Protein | 1 | 2005 | 309 | 0.02 | Why? |
| Pregnancy Outcome | 1 | 2017 | 3803 | 0.02 | Why? |
| Molecular Sequence Data | 1 | 2008 | 3198 | 0.02 | Why? |
| Hydrogen-Ion Concentration | 1 | 2006 | 993 | 0.02 | Why? |
| Viral Fusion Proteins | 1 | 2006 | 399 | 0.01 | Why? |
| Middle Aged | 4 | 2021 | 270681 | 0.01 | Why? |
| Protein Structure, Secondary | 1 | 2005 | 1077 | 0.01 | Why? |
| Aged | 3 | 2021 | 215776 | 0.01 | Why? |
| Recombinant Fusion Proteins | 1 | 2005 | 919 | 0.01 | Why? |
| Genome, Viral | 1 | 2021 | 13157 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2017 | 12447 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |
| Young Adult | 1 | 2021 | 93724 | 0.01 | Why? |
| Telemedicine | 1 | 2018 | 25032 | 0.01 | Why? |